ENDRA LIFE SCIENCES INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2604 USD | -7.73% |
|
-14.03% | -87.72% |
| 14/05 | Transcript : ENDRA Life Sciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENDRA LIFE SCIENCES INC. | Other Biotechnology & Medical Research | -7.73% | -14.03% | -87.72% | -83.31% | -98.75% | 31.14L |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NDRA Stock
- Charts ENDRA Life Sciences Inc.
- Comparison Chart
